KRAS and cancer: In addition, CTLA-4 gene expression level tended to be higher in CTCs and PBMCs in patients with KRAS mutation than in patients with KRAS wild type (data obtained from Gold Coast University Hospital and detected by next-generation sequencing on cancer tissue) (Figure 4B).